- Login To The User Panel and View The Entire Book Login
Within this first volume dealing with lung and kidney cancer, the editors and authors detail the latest research related to the application of artificial intelligence (AI) to cancer diagnosis and prognosis and summarize its advantages. It is the intention of the editors and authors to explore how AI assists in these activities, specifically with regard to its unprecedented accuracy, which is even higher than that of general statistical applications in oncology. Ways will also be demonstrated as to how these methods in AI are advancing the field. There have been thousands of papers written between 1995 and 2019 related to AI for cancer diagnosis and prognosis. However, to date (to the best of our knowledge) there has not yet been published a comprehensive overview of the latest findings pertaining to these AI technologies, within a single book project. Therefore, the purpose of this three-volume work, and particularly for this first volume dealing with lung and kidney cancer, is to present a compendium of these findings related to these two pervasive cancers. Within this coverage it is our hope that scientists, researchers and clinicians can successfully incorporate these techniques into other significant cancers such as pancreatic, esophageal leukemia, melanoma, etc. Part of IPEM-IOP Series in Physics and Engineering in Medicine and Biology.
Artificial Intelligence, oncology
Do you want to add Medilib to your home screen?